CYDY CYDY

CytoDyn (QB) Stock Price

0.415
-0.015 (-3.49%)
0.415
Volume 679,534
Bid Price 0.415
Ask Price 0.419
News -
Day High 0.4525

Low
0.2311

52 Week Range

High
2.17

Day Low 0.41
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.015 -3.49% 0.415 15:59:59
Open Price Low Price High Price Close Price Prev Close
0.4525 0.41 0.4525 0.415 0.43
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
281 679,534 $ 0.42481 $ 288,673 - 0.2311 - 2.17
Last Trade Time Type Quantity Stock Price Currency
15:59:59 322 $ 0.415 USD

Period:

Draw Mode:

CytoDyn Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 337.01M 812.08M 556.02M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
39.70M $ - - - -

more financials information »

CytoDyn (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.480.6190.3620.49301892,638,172-0.065-13.54%
1 Month0.46390.640.3620.52432341,352,319-0.0489-10.54%
3 Months0.431.300.3620.73421412,647,644-0.015-3.49%
6 Months0.4851.300.23110.54841422,433,612-0.07-14.43%
1 Year2.142.170.23110.73588312,558,279-1.73-80.61%
3 Years0.3510.010.23112.713,707,2070.06518.57%
5 Years0.6010.010.05522.582,367,696-0.185-30.83%

CytoDyn (QB) Description

CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions.
Your Recent History
USOTC
CYDY
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221002 15:47:51